Enhanced digital platform launches to transform NHS primary care clinical trials

A new digital platform has been launched to transform how NHS GP practices take part in clinical trials, making research quicker, easier and more inclusive for patients across the UK.

©StockSnap/Pixabay

©StockSnap/Pixabay

The DaRe2THINK clinical trial, led by the University of Birmingham and the Clinical Practice Research Datalink (CPRD), and run in partnership with NHS providers and the NIHR Research Delivery Network, has developed the platform to reduce paperwork for GP staff and reach communities often underrepresented in research. 

The platform securely links to GP systems, automatically transferring relevant health data to participating NHS General Practices, significantly reducing administrative burden on clinical staff. The enhanced functionality enables practice staff to rapidly identify suitable patient cohorts for NHS clinical trials and engage participants through integrated mobile messaging systems.

DaRe2THINK already securely screens routine healthcare records from more than 13m NHS patients across over 450 General Practices in England.

Puja Myles, director of CPRD at the MHRA, said: 'This platform represents a paradigm shift in how we conduct primary care research. By leveraging routine health data and advanced digital tools, we're removing traditional barriers that have prevented many communities from accessing the benefits of clinical trial participation.'

The current DaRe2THINK trial is investigating whether earlier intervention with NHS treatments can prevent blood clots and memory loss in patients with atrial fibrillation, a common heart rhythm condition associated with vascular dementia. Notably, 25% of participating practices are in England's most health-deprived areas, addressing long-standing inequalities in clinical research participation.

Dipak Kotecha, professor of cardiology at the University of Birmingham, said: ‘DaRe2THINK is leading the way to empower patients and provide an opportunity to take part in NHS clinical trials. The enhanced digital platform has now been rolled out across England, making it quicker and simpler for NHS staff to reach out to their patients, and embedding prevention into routine NHS care.'

Dr Alexandra Lee, a general practitioner at University of Birmingham, said: ‘The digital trial platform used in DaRe2THINK has had a positive impact on the delivery of primary care research and has helped recruit a new cohort of general practices that haven't previously taken part in clinical trials.'

The trial is funded by the NIHR Health Technology Assessment programme and supported by a dedicated public engagement team. The research was carried out at the NIHR Birmingham Biomedical Research Centre.

Healthcare leaders urged to tackle medical record snooping

Healthcare leaders urged to tackle medical record snooping

By Lee Peart 12 November 2026

The Information Commission's Office (ICO) has called on health leaders across the UK to act now to stop staff viewing medical records without a legitimate re...

Waiting list rises for third consecutive month in September

By Lee Peart 12 November 2026

The overall NHS waiting list rose for the third consecutive month from 7.37m to 7.38m in September.

GOSH appoints new chief digital information officer

By Lee Peart 12 November 2026

Dave Newey has been appointed chief digital information officer at Great Ormond Street Hospital NHS Foundation Trust (GOSH).


Popular articles by Liz Wells